Global Supply — Brandon, Manitoba

Pfizer Canada's manufacturing facility in Brandon, Manitoba, which employs close to 150 employees, is responsible for the collection of PMU, estrogen extraction process, quality control and distribution of conjugated estrogens to satisfy the demands for Canada, the US and all over the world - Europe, the Middle-East, the Orient and South America.

Conjugated Estrogen is used to produce Premarin, a hormone replacement therapy that accounts for more than two-thirds of all estrogen prescriptions in the United States and which is exported to more than 80 countries around the world. More Premarin is exported from Canada than any other single pharmaceutical product.

A network of 26 equine ranchers across Manitoba and Saskatchewan are responsible for providing the raw material needed to produce Premarin in Canada.

Prior to Pfizer's acquisition of Wyeth in October, 2009, the Facility in Brandon has earned the President's Bronze award (2008) and several safety awards, including the Award for Safety Achievement (2000 & 2004), Bronze Safety Award (2002, 2003, 2005, 2006, and 2008), and a Global Recognition Best Practice Award for Safety Culture (2006).